Search results
-
-
Blog
First-in-Human-Enabling Toxicology Programs: Common Misconceptions by Grace M. Furman
Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.
-
-
Blog
Best Practices for Nonclinical Dose Range Finding Studies
Explore dose range finding (DRF) studies in nonclinical research, from safety assessments to pharmacokinetics and biomarkers, ensuring optimized drug development.
-
Blog
Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD
Beatrice Setnik, PhD, discusses the mission of CCALC, the importance of abuse potential studies, and challenges in evaluating psychedelics for clinical use.
